Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia
Abebe A. Fola(John Brown University), Jeffrey A. Bailey(John Brown University), Hiwot Solomon(Federal Ministry of Health), Hassen Mamo(Addis Ababa University), Bokretsion G. Brhane(Ethiopian Public Health Institute), Jonathan B. Parr(University of North Carolina at Chapel Hill), Ashenafi Assefa(University of North Carolina at Chapel Hill), Beyene Petros(Addis Ababa University), Christopher M. Hennelly(University of North Carolina at Chapel Hill), Geremew Tasew(Ethiopian Public Health Institute), Jonathan J. Juliano(University of North Carolina at Chapel Hill), Emily Reichert(Analysis Group (United States)), Jane Cunningham(World Health Organization), Rebecca M. Crudal(Brown University), Sindew Mekasha Feleke(Ethiopian Public Health Institute)
Cited by 190
Related Papers
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863
Kidney Stone Disease: An Update on Current Concepts
|Advances in Urology|2018|833
A Worldwide Map of<i>Plasmodium falciparum</i>K13-Propeller Polymorphisms
|New England Journal of Medicine|2016|574
Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes
|The Journal of Infectious Diseases|2018|147
Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance
|The Lancet Infectious Diseases|2024|99